THE EVOLVING ROLE OF RADIOTHERAPY IN EARLY STAGE HODGKIN’S LYMPHOMA

Main Article Content

Umberto Ricardi
Radiation Oncology Department of Oncology University of Torino

Andrea Riccardo Filippi
Radiation Oncology Department of Oncology University of Torino

Cristina Piva
Radiation Oncology Department of Oncology University of Torino

Pierfrancesco Franco
Radiation Oncology U. Parini Hospital Aosta

Keywords

Hodgkin's Lymphoma, Radiotherapy,

Abstract

Radiation therapy has a key role in the combined modality treatment of early-stage Hodgkin’s Lymphoma (HL). Nevertheless, late toxicity still remains an issue. A modern approach in HL radiotherapy includes lower doses and smaller fields, together with the implementation of sophisticated and dedicated delivery techniques. Aim of the present review is to discuss the current role of radiotherapy and its potential future developments, with a focus on major clinical trials, technological advances and their repercussion in the clinical management of HL patients.

Downloads

Download data is not yet available.


Abstract 1811
PDF Downloads 762
HTML Downloads 6725
Figure 1 Downloads 0

Article Sidebar

PDF HTML Figure 1
Published
May 30, 2014
DOI https://doi.org/10.4084/mjhid.2014.035

Article Details

How to Cite

Ricardi, U. (2014) “THE EVOLVING ROLE OF RADIOTHERAPY IN EARLY STAGE HODGKIN’S LYMPHOMA”, Mediterranean Journal of Hematology and Infectious Diseases, 6(1), p. e2014035. doi: 10.4084/mjhid.2014.035.
Issue
Vol. 6 No. 1 (2014): Reviews, Articles, Case Reports and Letters
Section
Review Articles

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Transfer of Copyright and Permission to Reproduce Parts of Published Papers. Authors will grant copyright of their articles to the Institute of Hematology, Catholic University, Rome . No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.